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PREVALENCE OF SEROPOSITIVITY AGAINST HEPATITIS B VIRUS 
IN CHILDREN AGED 10 TO 15 YEARS WHO HAVE BEEN 
IMMUNIZED AGAINST HEPATITIS B IN INFANCY 
 
BACKGROUND: 
 Less is known regarding the duration and long term protection offered by hepatitis 
B vaccination and whether there is a need for booster doses of hepatitis B vaccine. This 
study determines the level of antibodies to hepatitis B surface antigen and analyses the 
prevalence of seropositivity. Though there are a number of studies from various 
countries, there are no Indian studies in this regard.  
METHODS: 
 Children aged 10 to 15 years who have received three hepatitis B vaccination 
doses before one year of age and who have records of the same are recruited for the 
study. Records are verified for the immunization status and confirmed. After getting 
proper consent for the study from the parent and obtaining assent from the children, 3 ml 
of blood sample is taken and levels of anti HBs levels determined by chemiluminescence 
immunoassay technique. 
RESULTS: 
 Of the 30 children aged 10 – 15 years who were vaccinated for hepatitis B before 
1 year of age,who were included in the study only 9 children had anti HBs levels > 
10mIU/mL. 
CONCLUSIONS: 
 Only 30% of the children who were vaccinated with the three doses of hepatitis B 
before infancy had protective titers of anti HBs antibodies. 




































































































